Literature DB >> 27334924

A Novel Interaction of the Catalytic Subunit of Protein Phosphatase 2A with the Adaptor Protein CIN85 Suppresses Phosphatase Activity and Facilitates Platelet Outside-in αIIbβ3 Integrin Signaling.

Tanvir Khatlani1, Subhashree Pradhan1, Qi Da1, Tanner Shaw1, Vladimir L Buchman2, Miguel A Cruz3, K Vinod Vijayan4.   

Abstract

The transduction of signals generated by protein kinases and phosphatases are critical for the ability of integrin αIIbβ3 to support stable platelet adhesion and thrombus formation. Unlike kinases, it remains unclear how serine/threonine phosphatases engage the signaling networks that are initiated following integrin ligation. Because protein-protein interactions form the backbone of signal transduction, we searched for proteins that interact with the catalytic subunit of protein phosphatase 2A (PP2Ac). In a yeast two-hybrid study, we identified a novel interaction between PP2Ac and an adaptor protein CIN85 (Cbl-interacting protein of 85 kDa). Truncation and alanine mutagenesis studies revealed that PP2Ac binds to the P3 block ((396)PAIPPKKPRP(405)) of the proline-rich region in CIN85. The interaction of purified PP2Ac with CIN85 suppressed phosphatase activity. Human embryonal kidney 293 αIIbβ3 cells overexpressing a CIN85 P3 mutant, which cannot support PP2Ac binding, displayed decreased adhesion to immobilized fibrinogen. Platelets contain the ∼85 kDa CIN85 protein along with the PP2Ac-CIN85 complex. A myristylated cell-permeable peptide derived from residues 395-407 of CIN85 protein (P3 peptide) disrupted the platelet PP2Ac-CIN85 complex and decreased αIIbβ3 signaling dependent functions such as platelet spreading on fibrinogen and thrombin-mediated fibrin clot retraction. In a phospho-profiling study P3 peptide treated platelets also displayed decreased phosphorylation of several signaling proteins including Src and GSK3β. Taken together, these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  adaptor protein; adhesion; fibrinogen; integrin; platelet; protein phosphatase 2A

Mesh:

Substances:

Year:  2016        PMID: 27334924      PMCID: PMC5016133          DOI: 10.1074/jbc.M115.704296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 2.  The beta3 integrin cytoplasmic tail: protein scaffold and control freak.

Authors:  S J Shattil
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

3.  I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins.

Authors:  M Li; Z Damuni
Journal:  Methods Mol Biol       Date:  1998

4.  SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins.

Authors:  S C Borinstein; M A Hyatt; V W Sykes; R E Straub; S Lipkowitz; J Boulter; O Bogler
Journal:  Cell Signal       Date:  2000-12       Impact factor: 4.315

5.  Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway.

Authors:  J L McConnell; R J Gomez; L R A McCorvey; B K Law; B E Wadzinski
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

6.  FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

Authors:  Qing Liu; Xiaobin Zhao; Frank Frissora; Yihui Ma; Ramasamy Santhanam; David Jarjoura; Amy Lehman; Danilo Perrotti; Ching-Shih Chen; James T Dalton; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2007-08-29       Impact factor: 22.113

7.  Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.

Authors:  O Mayevska; H Shuvayeva; N Igumentseva; S Havrylov; O Basaraba; Y Bobak; M Barska; N Volod'ko; J Baranska; V Buchman; L Drobot
Journal:  Exp Oncol       Date:  2006-12

8.  Protein phosphatase 2A negatively regulates integrin alpha(IIb)beta(3) signaling.

Authors:  Francisca C Gushiken; Vimal Patel; Yan Liu; Subhashree Pradhan; Angela L Bergeron; Yuandong Peng; K Vinod Vijayan
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

9.  Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.

Authors:  M Nishikawa; H Toyoda; M Saito; K Morita; I Tawara; K Deguchi; T Kuno; H Shima; M Nagao; S Shirakawa
Journal:  Cell Signal       Date:  1994-01       Impact factor: 4.315

10.  Structural basis of protein phosphatase 2A stable latency.

Authors:  Li Jiang; Vitali Stanevich; Kenneth A Satyshur; Mei Kong; Guy R Watkins; Brian E Wadzinski; Rituparna Sengupta; Yongna Xing
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  2 in total

Review 1.  Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.

Authors:  Jiansong Huang; Xia Li; Xiaofeng Shi; Mark Zhu; Jinghan Wang; Shujuan Huang; Xin Huang; Huafeng Wang; Ling Li; Huan Deng; Yulan Zhou; Jianhua Mao; Zhangbiao Long; Zhixin Ma; Wenle Ye; Jiajia Pan; Xiaodong Xi; Jie Jin
Journal:  J Hematol Oncol       Date:  2019-03-07       Impact factor: 17.388

2.  Human Placental Mesenchymal Stem/Stromal cells (pMSCs) inhibit agonist-induced platelet functions reducing atherosclerosis and thrombosis phenotypes.

Authors:  Abdullah Al Subayyil; Yasser S Basmaeil; Reem Alenzi; Tanvir Khatlani
Journal:  J Cell Mol Med       Date:  2021-09-18       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.